ClinConnect ClinConnect Logo
Search / Trial NCT06761248

Comparing Fluorescent Starch Nanoparticles Rinse with ICDAS for Early Caries Detection in Children

Launched by CAIRO UNIVERSITY · Dec 31, 2024

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Fluorescence Based Caries Detection Caries Detection Rinse Early Caries Detection Icdas Fsn

ClinConnect Summary

This clinical trial is looking at a new way to detect early tooth decay, known as dental caries, in children aged 6 to 11 years old. Researchers want to compare the effectiveness of a special rinse made with fluorescent starch nanoparticles to a standard method called the International Caries Detection and Assessment System (ICDAS). The goal is to see which method is better at identifying early signs of tooth decay in kids.

To participate in this study, children must have at least two teeth with early signs of decay (classified as ICDAS 1 or 2) and two teeth that do not have current decay. However, children with certain dental conditions, those wearing braces, or those whose parents do not agree to participate will not be included. If eligible, participants can expect to use the rinse and undergo assessments to help researchers learn more about the best ways to detect early tooth decay in children. This trial is not yet recruiting, so there will be more updates in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children with active initial caries.
  • At least two teeth with active caries (ICDAS 1 or 2) and two teeth with inactive caries.
  • Exclusion Criteria:
  • Teeth with hypoplasia, fractures, or conditions like dentinogenesis imperfecta.
  • Children with fixed orthodontic appliances.
  • Participants whose guardians refuse consent.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, Giza, Egypt

Patients applied

0 patients applied

Trial Officials

Associate Prof. Dr. Mariam Mohsen aly, Ph.D.

Study Director

Cairo University

Dr. Reem Mohamed Fouad Wahby, Ph.D.

Study Chair

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported